Respiratory Drugs Market Revenue 2024 to 2034
Respiratory Drugs Market Revenue 2024 to 2034
The respiratory drugs market size is forecast to grow at a CAGR of 5.8%, from USD 18.55 billion in 2025 to USD 30.81 billion by 2034, over the forecast period from 2025 to 2034.
Report ID: 10136
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 17.53 Bn
Forecast Year,
USD USD 30.81 Bn
CAGR, 2025 -
5.8%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Respiratory Drugs Market Size Analysis
Respiratory Drugs Market Size By Disease Type 2024 to 2034 (USD )
| Disease Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asthma | 4.38 | 4.64 | 4.92 | 5.21 | 5.52 | 5.84 | 6.19 | 6.56 | 6.95 | 7.36 | 7.79 |
| Chronic Obstructive Pulmonary Disease (COPD) | 4.38 | 4.64 | 4.91 | 5.20 | 5.51 | 5.83 | 6.18 | 6.54 | 6.92 | 7.33 | 7.76 |
| Lung Cancer | 2.63 | 2.78 | 2.95 | 3.12 | 3.30 | 3.50 | 3.70 | 3.92 | 4.15 | 4.39 | 4.65 |
| Respiratory Tract Infection | 1.75 | 1.85 | 1.96 | 2.07 | 2.19 | 2.31 | 2.44 | 2.58 | 2.73 | 2.89 | 3.05 |
| Allergic Rhinitis | 1.40 | 1.48 | 1.57 | 1.65 | 1.75 | 1.85 | 1.95 | 2.06 | 2.18 | 2.30 | 2.43 |
| Cystic Fibrosis (CF) | 1.23 | 1.30 | 1.37 | 1.45 | 1.53 | 1.62 | 1.71 | 1.80 | 1.90 | 2.01 | 2.13 |
| Others | 1.75 | 1.85 | 1.95 | 2.06 | 2.17 | 2.29 | 2.41 | 2.55 | 2.69 | 2.83 | 2.99 |
Respiratory Drugs Market Size By Drug Class 2024 to 2034 (USD )
| Drug Class | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Bronchodilators | 3.51 | 3.71 | 3.94 | 4.17 | 4.42 | 4.68 | 4.96 | 5.26 | 5.57 | 5.90 | 6.25 |
| Corticosteroids | 3.16 | 3.34 | 3.54 | 3.75 | 3.97 | 4.21 | 4.46 | 4.72 | 5.00 | 5.29 | 5.61 |
| Combination Drugs | 2.98 | 3.15 | 3.33 | 3.52 | 3.73 | 3.94 | 4.16 | 4.40 | 4.66 | 4.92 | 5.21 |
| Antibiotics | 2.10 | 2.23 | 2.36 | 2.50 | 2.64 | 2.80 | 2.97 | 3.14 | 3.32 | 3.52 | 3.73 |
| Target Therapy | 1.75 | 1.86 | 1.97 | 2.08 | 2.21 | 2.34 | 2.47 | 2.62 | 2.77 | 2.94 | 3.11 |
| Immunotherapy | 1.40 | 1.49 | 1.57 | 1.67 | 1.77 | 1.87 | 1.98 | 2.10 | 2.22 | 2.36 | 2.50 |
| CFTR | 1.23 | 1.30 | 1.37 | 1.45 | 1.54 | 1.63 | 1.72 | 1.82 | 1.93 | 2.04 | 2.16 |
| Others | 1.40 | 1.47 | 1.54 | 1.62 | 1.70 | 1.78 | 1.86 | 1.95 | 2.05 | 2.15 | 2.25 |
Respiratory Drugs Market Size By Route of Administration 2024 to 2034 (USD )
| Route of Administration | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oral | 7.01 | 7.42 | 7.86 | 8.32 | 8.80 | 9.32 | 9.86 | 10.44 | 11.05 | 11.70 | 12.38 |
| Nasal | 6.14 | 6.49 | 6.87 | 7.27 | 7.70 | 8.15 | 8.62 | 9.12 | 9.65 | 10.22 | 10.81 |
| Injectable | 4.38 | 4.63 | 4.89 | 5.17 | 5.46 | 5.77 | 6.10 | 6.45 | 6.81 | 7.20 | 7.61 |
Respiratory Drugs Market Size By Distribution Channel 2024 to 2034 (USD )
| Distribution Channel | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacies | 7.89 | 8.35 | 8.84 | 9.36 | 9.91 | 10.49 | 11.11 | 11.76 | 12.45 | 13.18 | 13.96 |
| Retail Pharmacies | 7.01 | 7.41 | 7.84 | 8.29 | 8.77 | 9.27 | 9.81 | 10.37 | 10.96 | 11.59 | 12.26 |
| Online Pharmacies | 2.63 | 2.78 | 2.94 | 3.11 | 3.29 | 3.47 | 3.67 | 3.88 | 4.11 | 4.34 | 4.59 |
Respiratory Drugs Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 6.66 | 7.06 | 7.48 | 7.93 | 8.40 | 8.90 | 9.43 | 9.99 | 10.59 | 11.22 | 11.89 |
| Europe | 4.73 | 5.00 | 5.28 | 5.58 | 5.90 | 6.23 | 6.58 | 6.95 | 7.34 | 7.76 | 8.19 |
| Asia-Pacific | 3.86 | 4.09 | 4.34 | 4.60 | 4.88 | 5.17 | 5.48 | 5.81 | 6.16 | 6.54 | 6.93 |
| Latin America | 1.23 | 1.29 | 1.36 | 1.43 | 1.51 | 1.59 | 1.68 | 1.77 | 1.86 | 1.96 | 2.06 |
| Middle East & Africa | 1.05 | 1.11 | 1.16 | 1.22 | 1.28 | 1.35 | 1.42 | 1.49 | 1.56 | 1.64 | 1.73 |
Respiratory Drugs Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
